NLRP3 and diabetic cardiomyopathy: Wang et al. found that NLRP3 is involved in the occurrence of myocardial ferroptosis in diabetic cardiomyopathy, and inhibiting NLRP3 both in vivo and in vitro can suppress diabetic-induced myocardial ferroptosis and trigger myocardial injury [99].